![]() |
Medically Speaking |
| [
January/February 2003 ]
Digital Infrared Thermal Imaging ~ A New Form of Breast Cancer Screening by Mike Wedge Imagine being able to "see" pain, or locate a potential breast cancer years before mammography or ultrasonography can. What if you could visually monitor the efficacy of pain treatment? Sound exciting? Now, what if I told you there is an imaging procedure that does all this without pain or radiation, and with no body contact? The procedure is Digital Infrared Thermal Imaging (DITI). DITI is an FDA approved procedure that has been around for decades, but recent advances in technology and computer interpretation have brought DITI into more common usage. In 1982, the FDA approved thermal imaging for beast cancer screening. Although DITI is most commonly used for breast cancer screening, other uses include evaluation of chronic pain syndromes, neurovascular pathology, nerve root compression and more. DITI is capable of locating pathology even in the absence of positive findings on MRI or other imaging procedures. While there are multiple uses for DITI, I will discuss its place in breast cancer screening. Breast cancer currently affects one in eight women over the course of their life. Every three minutes, another woman is diagnosed with breast cancer and every 14 minutes a woman will die from breast cancer. Mammography remains the primary screening method, but its efficacy is debated, especially in women under 50. Breast self exam (BSE) has also come under scrutiny. It appears from recent research that neither BSE nor mammographies are reducing cancer deaths. Put another way, mortality rates have changed little over the last four decades. There may be a three to four percent improvement since 1990, but this may be related to the way survival rates are calculated, rather than to an actual decrease in mortality. The reason for the grim statistics is that by the time a woman finds a tumor, it has probably been present for several years. This detection is not early enough. Mammography, breast MRI, and sonograms all utilize anatomical imaging.
This is fine and necessary, but a mass has to be present and large enough
to be seen. Breast MRI is arguably the best approach, but as far I understand
it a mass needs to be at least 3 mm in size to be seen. DITI is an evaluation
of physiology, rather then anatomy and is capable of "seeing"
precancerous and cancerous states before a tumor is large enough to
be seen by anatomical imaging. If a thermogram indicates a potential problem, anatomical imaging is the next step. If a mass is found, then a standard protocol is followed. If no mass is found, a precancerous condition may exist and steps are taken to reverse this trend. A follow-up thermogram is taken three to six months from the original to monitor changes, both good and bad. Several points to consider:
For more information contact Michael Wedge, L.Ac., DCH at 745-7928. To see scan images, visit our web site at www.physioscan.net . |